Literature DB >> 7539971

The multimeric nonstructural NS2 proteins of bluetongue virus, African horsesickness virus, and epizootic hemorrhagic disease virus differ in their single-stranded RNA-binding ability.

J M Uitenweerde1, J Theron, M A Stoltz, H Huismans.   

Abstract

The structure and single-stranded (ss) RNA-binding by the nonstructural protein NS2 of three different orbiviruses were studied and compared. African horsesickness virus (AHSV), bluetongue virus (BTV), and epizootic hemorrhagic disease virus (EHDV) were analyzed in recombinant baculovirus-infected cells and in cells infected with BTV and AHSV. Sedimentation analysis and nonreducing SDS-PAGE revealed that NS2 of all three orbiviruses is a 7S multimer with both inter- and intramolecular disulfide bonds, probably consisting of six or more NS2 molecules. The 7S NS2 multimer of all three viruses binds ssRNA but there is a marked disparity in the ssRNA-binding ability between the three proteins. At physiological salt concentration, BTV NS2 binds ssRNA very efficiently, whereas AHSV NS2 shows only a low efficiency for binding ssRNA. EHDV NS2 binds with intermediate efficiency. The result was the same irrespective of whether poly(U)-Sepharose or viral mRNA was used, indicating that ssRNA-binding by NS2 is nonspecific. The difference in RNA-binding ability may be related to the alpha-helix content of the respective proteins. NS2 of BTV has the highest predicted alpha-helix content followed by EHDV and AHSV. The ability of the NS2 proteins to form virus inclusion body-like structures in baculovirus-infected cells is not affected by the ssRNA-binding disparity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539971     DOI: 10.1006/viro.1995.1294

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Localization of the single-stranded RNA-binding domains of bluetongue virus nonstructural protein NS2.

Authors:  G C Fillmore; H Lin; J K K Li
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Identification and characterization of the helix-destabilizing activity of rotavirus nonstructural protein NSP2.

Authors:  Z F Taraporewala; J T Patton
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Site-specific mutations in the NS2 protein of epizootic haemorrhagic disease virus markedly affect the formation of cytoplasmic inclusion bodies.

Authors:  J Theron; H Huismans; L H Nel
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Multimers formed by the rotavirus nonstructural protein NSP2 bind to RNA and have nucleoside triphosphatase activity.

Authors:  Z Taraporewala; D Chen; J T Patton
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  The reovirus protein mu2, encoded by the M1 gene, is an RNA-binding protein.

Authors:  L Brentano; D L Noah; E G Brown; B Sherry
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Reovirus protein sigmaNS binds in multiple copies to single-stranded RNA and shares properties with single-stranded DNA binding proteins.

Authors:  A L Gillian; S C Schmechel; J Livny; L A Schiff; M L Nibert
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Reovirus sigma NS and mu NS proteins form cytoplasmic inclusion structures in the absence of viral infection.

Authors:  Michelle M Becker; Timothy R Peters; Terence S Dermody
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Specific binding of Bluetongue virus NS2 to different viral plus-strand RNAs.

Authors:  Kostas Lymperopoulos; Rob Noad; Sara Tosi; Suran Nethisinghe; Ian Brierley; Polly Roy
Journal:  Virology       Date:  2006-07-26       Impact factor: 3.616

9.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

10.  Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies.

Authors:  Jens Modrof; Kostas Lymperopoulos; Polly Roy
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.